Mechanisms of activation of receptor tyrosine kinases: Monomers or dimers

Cells

Volumn 3, Issue 2, 2014, Pages 304-330

  Maruyama, Ichiro N ^a  

^a OKINAWA INSTITUTE OF SCIENCE AND TECHNOLOGY GRADUATE UNIVERSITY   (Japan)

Author keywords

BDNF; Cancer; Dimerization; EGFR; IGF; Ligand; NGF; Phosphorylation; Rotation twist; Transmembrane signaling; Trk

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR RECEPTOR; DIMER; EPIDERMAL GROWTH FACTOR RECEPTOR; HETERODIMER; INSULIN RECEPTOR; ISOENZYME; MONOMER; NEUROTROPHIN 3 RECEPTOR; NEUROTROPHIN RECEPTOR; PROTEIN TYROSINE KINASE; PROTEIN TYROSINE KINASE A; TYROSINE;

AUTOPHOSPHORYLATION; DIMERIZATION; DISULFIDE BOND; ENZYME ACTIVATION; HUMAN; LIGAND BINDING; NERVE CELL PLASTICITY; NONHUMAN; PH; PROTEIN DOMAIN; PROTEIN EXPRESSION; RECEPTOR BINDING; REVIEW; SEQUENCE HOMOLOGY;

EID: 84908268069     PISSN: None     EISSN: 20734409     Source Type: Journal    
DOI: 10.3390/cells3020304     Document Type: Review

References (213)

1. Blume-Jensen, P.; Hunter, T. Oncogenic kinase signaling. Nature 2001, 411, 355-365.
2. Blagoev, B.; Ong, S. E.; Kratchmarova, I.; Mann, M. Temporal analysis of phosphotyrosine-dependent signaling networks by quantitative proteomics. Nat. Biotechnol. 2004, 22, 1139-1145.
3. Bradshaw, R. A.; Chalkley, R. J.; Biarc, J.; Burlingame, A. L. Receptor tyrosine kinase signaling mechanisms: Devolving TrkA responses with phosphoproteomics. Adv. Biol. Regul. 2013, 53, 87-96.
4. Gotoh, N.; Tojo, A.; Hino, M.; Yazaki, Y.; Shibuya, M. A highly conserved tyrosine residue at codon 845 within the kinase domain is not required for the transforming activity of human epidermal growth factor receptor. Biochem. Biophys. Res. Commun. 1992, 186, 768-774.
5. Hubbard, S. R.; Till, J. H. Protein tyrosine kinase structure and function. Annu. Rev. Biochem. 2000, 69, 373-398.
6. Pawson, T. Regulation and targets of receptor tyrosine kinases. Eur. J. Cancer 2002, 38, S3-S10.
7. Lemmon, M. A.; Schlessinger, J. Cell signaling by receptor tyrosine kinases. Cell 2010, 141, 1117-1134.
8. Schlessinger, J. Cell signaling by receptor tyrosine kinases. Cell 2000, 103, 211-225.
9. Ullrich, A.; Schlessinger, J. Signal transduction by receptors with tyrosine kinase activity. Cell 1990, 61, 203-212.
10. Heldin, C. H. Dimerization of cell surface receptors in signal transduction. Cell 1995, 80, 213-223.
11. Schlessinger, J. Ligand-induced, receptor-mediated dimerization and activation of EGF receptor. Cell 2002, 110, 669-672.
12. Burgess, A. W.; Cho, H. S.; Eigenbrot, C.; Ferguson, K. M.; Garrett, T. P.; Leahy, D. J.; Lemmon, M. A.; Sliwkowski, M. X.; Ward, C. W.; Yokoyama, S. An open-and-shut case? Recent insights into the activation of EGF/ErbB receptors. Mol. Cell 2003, 12, 541-552.
13. Bublil, E. M.; Yarden, Y. The EGF receptor family: Spearheading a merger of signaling and therapeutics. Curr. Opin. Cell Biol. 2007, 19, 124-134.
14. Endres, N. F.; Das, R.; Smith, A. W.; Arkhipov, A.; Kovacs, E.; Huang, Y.; Pelton, J. G.; Shan, Y.; Shaw, D. E.; Wemmer, D. E.; et al. Conformational coupling across the plasma membrane in activation of the EGF receptor. Cell 2013, 152, 543-556.
15. Moriki, T.; Maruyama, H.; Maruyama, I. N. Activation of preformed EGF receptor dimers by ligand-induced rotation of the transmembrane domain. J. Mol. Biol. 2001, 311, 1011-1026.
16. Martin-Fernandez, M.; Clarke, D. T.; Tobin, M. J.; Jones, S. V.; Jones, G. R. Preformed oligomeric epidermal growth factor receptors undergo an ectodomain structure change during signaling. Biophys. J. 2002, 82, 2415-2427.
17. Yu, X.; Sharma, K. D.; Takahashi, T.; Iwamoto, R.; Mekada, E. Ligand-independent dimer formation of epidermal growth factor receptor (EGFR) is a step separable from ligand-induced EGFR signaling. Mol. Biol. Cell 2002, 13, 2547-2557.
18. Clayton, A. H.; Walker, F.; Orchard, S. G.; Henderson, C.; Fuchs, D.; Rothacker, J.; Nice, E. C.; Burgess, A. W. Ligand-induced dimer-tetramer transition during the activation of the cell surface epidermal growth factor receptor-A multidimensional microscopy analysis. J. Biol. Chem. 2005, 280, 30392-30399.
19. Teramura, Y.; Ichinose, J.; Takagi, H.; Nishida, K.; Yanagida, T.; Sako, Y. Single-molecule analysis of epidermal growth factor binding on the surface of living cells. EMBO J. 2006, 25, 4215-4222.
20. Liu, P.; Sudhaharan, T.; Koh, R. M.; Hwang, L. C.; Ahmed, S.; Maruyama, I. N.; Wohland, T. Investigation of the dimerization of proteins from the epidermal growth factor receptor family by single wavelength fluorescence cross-correlation spectroscopy. Biophys. J. 2007, 93, 684-698.
21. Saffarian, S.; Li, Y.; Elson, E. L.; Pike, L. J. Oligomerization of the EGF receptor investigated by live cell fluorescence intensity distribution analysis. Biophys. J. 2007, 93, 1021-1031.
22. Tao, R. H.; Maruyama, I. N. All EGF(ErbB) receptors have preformed homo-and heterodimeric structures in living cells. J. Cell Sci. 2008, 121, 3207-3217.
23. Bader, A. N.; Hofman, E. G.; Voortman, J.; En Henegouwen, P. M.; Gerritsen, H. C. Homo-FRET imaging enables quantification of protein cluster sizes with subcellular resolution. Biophys. J. 2009, 97, 2613-2622.
24. Yang, K. S.; Ilagan, M. X.; Piwnica-Worms, D.; Pike, L. J. Luciferase fragment complementation imaging of conformational changes in the epidermal growth factor receptor. J. Biol. Chem. 2009, 284, 7474-7482.
25. Ma, X.; Ahmed, S.; Wohland, T. EGFR activation monitored by SW-FCCS in live cells. Front. Biosci. (Elite Ed.) 2011, 3, 22-32.
26. Shen, J.; Maruyama, I. N. Nerve growth factor receptor TrkA exists as a preformed, yet inactive, dimer in living cells. FEBS Lett. 2011, 585, 295-299.
27. Shen, J.; Maruyama, I. N. Brain-derived neurotrophic factor receptor TrkB exists as a preformed dimer in living cells. J. Mol. Signal. 2012, 7, 2.
28. Macdonald-Obermann, J. L.; Piwnica-Worms, D.; Pike, L. J. Mechanics of EGF receptor/ErbB2 kinase activation revealed by luciferase fragment complementation imaging. Proc. Natl. Acad. Sci. USA 2012, 109, 137-142.
29. Macdonald-Obermann, J. L.; Adak, S.; Landgraf, R.; Piwnica-Worms, D.; Pike, L. J. Dynamic analysis of the epidermal growth factor (EGF) receptor-ErbB2-ErbB3 protein network by luciferase fragment complementation imaging. J. Biol. Chem. 2013, 288, 30773-30784.
30. Ward, C. W.; Lawrence, M. C.; Streltsov, V. A.; Adams, T. E.; McKern, N. M. The insulin and EGF receptor structures: New insights into ligand-induced receptor activation. Trends Biochem. Sci. 2007, 32, 129-137.
31. Cohen, S. Isolation of a mouse submaxillary gland protein accelerating incisor eruption and eyelid opening in the new-born animal. J. Biol. Chem. 1962, 237, 1555-1562.
32. Carpenter, G.; Lembach, K. J.; Morrison, M. M.; Cohen, S. Characterization of the binding of 125-I-labeled epidermal growth factor to human fibroblasts. J. Biol. Chem. 1975, 250, 4297-4304.
33. Holbro, T.; Hynes, N. E. ErbB receptors: Directing key signaling networks throughout life. Annu. Rev. Pharmacol. Toxicol. 2004, 44, 195-217.
34. Yarden, Y.; Sliwkowski, M. X. Untangling the ErbB signaling network. Nat. Rev. Mol. Cell Biol. 2001, 2, 127-137.
35. Olayioye, M. A.; Neve, R. M.; Lane, H. A.; Hynes, N. E. The ErbB signaling network: Receptor heterodimerization in development and cancer. EMBO J. 2000, 19, 3159-3167.
36. Hynes, N. E.; MacDonald, G. ErbB receptors and signaling pathways in cancer. Curr. Opin. Cell Biol. 2009, 21, 177-184.
37. Gassmann, M.; Casagranda, F.; Orioli, D.; Simon, H.; Lai, C.; Klein, R.; Lemke, G. Aberrant neural and cardiac development in mice lacking the ErbB4 neuregulin receptor. Nature 1995, 378, 390-394.
38. Tidcombe, H.; Jackson-Fisher, A.; Mathers, K.; Stern, D. F.; Gassmann, M.; Golding, J. P. Neural and mammary gland defects in ErbB4 knockout mice genetically rescued from embryonic lethality. Proc. Natl. Acad. Sci. USA 2003, 100, 8281-8286.
39. Hynes, N. E.; Lane, H. A. ERBB receptors and cancer: The complexity of targeted inhibitors. Nat. Rev. Cancer 2005, 5, 341-354.
40. Harris, R. C.; Chung, E.; Coffey, R. J. EGF receptor ligands. Exp. Cell Res. 2003, 284, 2-13.
41. Lemmon, M. A. Ligand-induced ErbB receptor dimerization. Exp. Cell Res. 2009, 315, 638-648.
42. Jorissen, R. N.; Walker, F.; Pouliot, N.; Garrett, T. P.; Ward, C. W.; Burgess, A. W. Epidermal growth factor receptor: Mechanisms of activation and signaling. Exp. Cell Res. 2003, 284, 31-53.
43. Ward, C. W.; Garrett, T. P. J. The relationship between the L1 and L2 domains of the insulin and epidermal growth factor receptors and leucine-rich repeat modules. BMC Bioinform. 2001, 2, 4.
44. Ward, C. W.; Garrett, T. P. J.; McKern, N. M.; Lou, M.; Cosgrove, L. J.; Sparrow, L. G.; Frenkel, M. J.; Hoyne, P. A.; Elleman, T. C.; Adams, T. E.; et al. The three dimensional structure of the type I insulin-like growth factor receptor. Mol. Pathol. 2001, 54, 125-132.
45. Wilson, K. J.; Gilmore, J. L.; Foley, J.; Lemmon, M. A.; Riese, D. J., 2nd. Functional selectivity of EGF family peptide growth factors: Implications for cancer. Pharmacol. Ther. 2009, 122, 1-8.
46. Karunagaran, D.; Tzahar, E.; Beerli, R. R.; Chen, X.; Graus-Porta, D.; Ratzkin, B. J.; Seger, R.; Hynes, N. E; Yarden, Y. ErbB-2 is a common auxiliary subunit of NDF and EGF receptors: Implications for breast cancer. EMBO J. 1996, 15, 254-264.
47. Tzahar, E.; Waterman, H.; Chen, X.; Levkowitz, G.; Karunagaran, D.; Lavi, S.; Ratzkin, B. J.; Yarden, Y. A hierarchical network of interreceptor interactions determines signal transduction by Neu differentiation factor/neuregulin and epidermal growth factor. Mol. Cell. Biol. 1996, 16, 5276-5287.
48. Graus-Porta, D.; Beerli, R. R.; Daly, J. M.; Hynes, N. E. ErbB-2, the preferred heterodimerization partner of all ErbB receptors, is a mediator of lateral signaling. EMBO J. 1997, 16, 1647-1655.
49. Klapper, L. N.; Glathe, S.; Vaisman, N.; Hynes, N. E.; Andrews, G. C.; Sela, M.; Yarden, Y. The ErbB-2/HER2 oncoprotein of human carcinomas may function solely as a shared coreceptor for multiple stroma-derived growth factors. Proc. Natl. Acad. Sci. USA 1999, 96, 4995-5000.
50. Guy, P. M.; Platko, J. V.; Cantley, L. C.; Cerione, R. A.; Carraway, K. L., 3rd. Insect cell-expressed p180erbB3 possesses an impaired tyrosine kinase activity. Proc. Natl. Acad. Sci. USA 1994, 91, 8132-8136.
51. Sierke, S. L.; Cheng, K.; Kim, H. H.; Koland, J. G. Biochemical characterization of the protein tyrosine kinase homology domain of the ErbB3 (HER3) receptor protein. Biochem. J. 1997, 322, 757-763.
52. Prigent, S. A.; Gullick, W. J. Identification of c-erbB-3 binding sites for phosphatidylinositol 3'-kinase and SHC using an EGF receptor/c-erbB-3 chimera. EMBO J. 1994, 13, 2831-2841.
53. Wallasch, C.; Weiss, F. U.; Niederfellner, G.; Jallal, B.; Issing, W.; Ullrich, A. Heregulin-dependent regulation of HER2/neu oncogenic signaling by heterodimerization with HER3. EMBO J. 1995, 14, 4267-4275.
54. Shi, F.; Telesco, S. E.; Liu, Y.; Radhakrishnan, R.; Lemmon, M. A. ErbB3/HER3 intracellular domain is competent to bind ATP and catalyze autophosphorylation. Proc. Natl. Acad. Sci. USA 2010, 107, 7692-7697.
55. Zhang, Q.; Park, E.; Kani, K.; Landgraf, R. Functional isolation of activated and unilaterally phosphorylated heterodimers of ERBB2 and ERBB3 as scaffolds in ligand-dependent signaling. Proc. Natl. Acad. Sci. USA 2012, 109, 13237-13242.
56. Levi-Montalcini, R.; Angeletti, P. U. Essential role of the nerve growth factor in the survival and maintenance of dissociated sensory and sympathetic embryonic nerve cells in vitro. Dev. Biol. 1963, 7, 653-659.
57. Lai, K. O.; Fu, W. Y.; Ip, F. C.; Ip, N. Y. Cloning and expression of a novel neurotrophin, NT-7, from carp. Mol. Cell. Neurosci. 1998, 11, 64-76.
58. Kaplan, D. R.; Hempstead, B. L.; Martin-Zanca, D.; Chao, M. V.; Parada, L. F. The trk proto-oncogene product: A signal transducing receptor for nerve growth factor. Science 1991, 252, 554-558.
59. Ip, N. Y.; Ibanez, C. F.; Nye, S. H.; McClain, J.; Jones, P. F.; Gies, D. R.; Belluscio, L.; Le Beau, M. M.; Espinosa, R., 3rd; Squinto, S. P.; et al. Mammalian neurotrophin-4: Structure, chromosomal localization, tissue distribution, and receptor specificity. Proc. Natl. Acad. Sci. USA 1992, 89, 3060-3064.
60. Klein, R.; Nanduri, V.; Jing, S. A.; Lamballe, F.; Tapley, P.; Bryant, S.; Cordon-Cardo, C.; Jones, K. R.; Reichardt, L. F.; Barbacid, M. The trkB tyrosine protein kinase is a receptor for brain-derived neurotrophic factor and neurotrophin-3. Cell 1991, 66, 395-403.
61. Lamballe, F.; Klein, R.; Barbacid, M. trkC, a new member of the trk family of tyrosine protein kinases, is a receptor for neurotrophin-3. Cell 1991, 66, 967-979.
62. Soppet, D.; Escandon, E.; Maragos, J.; Middlemas, D. S.; Reid, S. W.; Blair, J.; Burton, L. E.; Stanton, B. R.; Kaplan, D. R.; Hunter, T.; et al. The neurotrophic factors brain-derived neurotrophic factor and neurotrophin-3 are ligands for the trkB tyrosine kinase receptor. Cell 1991, 65, 895-903.
63. Squinto, S. P.; Stitt, T. N.; Aldrich, T. H.; Davis, S.; Bianco, S. M.; Radziejewski, C.; Glass, D. J.; Masiakowski, P.; Furth, M. E.; Valenzuela, D. M.; et al. trkB encodes a functional receptor for brain-derived neurotrophic factor and nejurotrophin-3 but not nerve growth factor. Cell 1991, 65, 885-893.
64. Rodriguez-Tebar, A.; Dechant, G.; Gotz, R.; Barde, Y. A. Binding of neurotrophin-3 to its neuronal receptors and interactions with nerve growth factor and brain-derived neurotrophic factor. EMBO J. 1992, 11, 917-922.
65. Barbacid, M. The Trk family of neurotrophin receptors. J. Neurobiol. 1994, 25, 1386-1403.
66. Huang, E. J.; Reichardt, L. F. Trk receptors: Roles in neuronal signal transduction. Annu. Rev. Biochem. 2003, 72, 609-642.
67. Lessmann, V.; Brigadski, T. Mechanisms, locations, and kinetics of synaptic BDNF secretion: An update. Neurosci. Res. 2009, 65, 11-22.
68. Lessmann, V.; Gottmann, K.; Malcangio, M. Neurotrophin secretion: Current facts and future prospects. Prog. Neurobiol. 2003, 69, 341-374.
69. Chao, M. V.; Rajagopal, R.; Lee, F. S. Neurotrophin signalling in health and disease. Clin. Sci. (Lond.) 2006, 110, 167-173.
70. Kaplan, D. R.; Martin-Zanca, D.; Parada, L. F. Tyrosine phosphorylation and tyrosine kinase activity of the trk proto-oncogene product induced by NGF. Nature 1991, 350, 158-160.
71. Hempstead, B. L.; Martin-Zanca, D.; Kaplan, D. R.; Parada, L. F.; Chao, M. V. High-affinity NGF binding requires coexpression of the trk proto-oncogene and the low-affinity NGF receptor. Nature 1991, 350, 678-683.
72. Klein, R.; Lamballe, F.; Bryant, S.; Barbacid, M. The trkB tyrosine protein kinase is a receptor for neurotrophin-4. Neuron 1992, 8, 947-956.
73. Cordon-Cardo, C.; Tapley, P.; Jing, S. Q.; Nanduri, V.; O'Rourke, E.; Lambelle, F.; Kovary, K.; Klein, R.; Jones, K. R.; Reichardt, L. F.; et al. The trk tyrosine protein kinase mediates the mitogenic properties of nerve growth factor and neurotrophin-3. Cell 1991, 66, 173-183.
74. Simi, A.; Ibáñez, C. F. Assembly and activation of neurotrophic factor receptor complexes. Dev. Neurobiol. 2010, 70, 323-331.
75. Chao, M. V. Neurotrophins and their receptors: A convergence point for many signaling pathways. Nat. Rev. Neurosci. 2003, 4, 299-309.
76. Kaplan, D. R.; Miller, F. D. Neurotrophin signal transduction in the nervous system. Curr. Opin. Neurobiol. 2000, 10, 381-391.
77. Nakagawara, A. Trk receptor tyrosine kinases: A bridge between cancer and neural development. Cancer Lett. 2001, 169, 107-114.
78. Brodeur, G. M.; Minturn, J. E.; Ho, R.; Simpson, A. M.; Lyer, R.; Varela, C. R.; Light, J. E.; Kolla, V.; Evans, A. E. Trk receptor expression and inhibition in neuroblastomas. Clin. Cancer Res. 2009, 15, 3244-3250.
79. Tognon, C.; Knezevich, S. R.; Huntsman, D.; Roskelley, C. D.; Melnyk, N.; Mathers, J. A.; Becker, L.; Carneiro, F.; MacPherson, N.; Horsman, D.; et al. Expression of the ETV6-NTRK3 gene fusion as a primary event in human secretory breast carcinoma. Cancer Cell 2002, 2, 367-376.
80. Schneider, R.; Schweiger, M. A novel modular mosaic of cell adhesion motifs in the extracellular domains of the neurogenic trk and trkB tyrosine kinase receptors. Oncogene 1991, 6, 1807-1811.
81. Bertrand, T.; Kothe, M.; Liu, J.; Dupuy, A.; Rak, A.; Berne, P. F.; Davis, S.; Gladysheva, T.; Valtre, C.; et al. The crystal structures of TrkA and TrkB suggest key regions for achieving selective inhibition. J. Mol. Biol. 2012, 423, 439-453.
82. Holden, P. H.; Asopa, V.; Robertson, A. G.; Clarke, A. R.; Tyler, S.; Bennett, G. S.; Brain, S. D.; Wilcock, G. K.; Allen, S. J.; Smith, S. K.; et al. Immunogloblin-like domains define the nerve growth factor binding site of the TrkA receptor. Nat. Biotechnol. 1997, 15, 668-672.
83. Perez, P.; Coll, P. M.; Hempstead, B. L.; Martin-Zanca, D.; Chao, M. V. NGF binding to the trk tyrosine kinase receptor requires the extracellular immunoglobulin-like domains. Mol. Cell. Neurosci. 1995, 6, 97-105.
84. Urfer, R.; Tsoulfas, P.; O'Connell, L.; Presta, L. G. Specificity determinants in neurotrophin-3 and design of nerve growth factor-based trkC agonists by changing central β-strand bundle residues of their neurotrophin-3 analogs. Biochemistry 1997, 36, 4775-4781.
85. Ultsch, M. H.; Wiesmann, C.; Simmons, L. C.; Henrich, J.; Yang, M.; Reilly, D.; Bass, S. H.; de Vos, A. M. Crystal structures of the neurotrophin-binding domain of TrkA, TrkB and TrkC. J. Mol. Biol. 1999, 290, 149-159.
86. Wiesmann, C.; Ultsch, M. H.; Bass, S. H.; de Vos, A. M. Crystal structure of nerve growth factor in complex with the ligand-binding domain of the TrkA receptor. Nature 1999, 401, 184-188.
87. Steiner, D. F. Insulin Today. Diabetes 1976, 26, 322-340.
88. Levine, R.; Goldstein, M.; Klein, S.; Huddlestun, B. The action of insulin on the distribution of galactose in eviscerated nephrectomized dogs. J. Biol. Chem. 1949, 179, 985-986.
89. Renehan, A. G.; Brennan, B. M. Acromegaly, growth hormone and cancer risk. Best Pract. Res. Clin. Endocrinol. Metab. 2008, 22, 639-657.
90. Walenkamp, M. J. E.; Wit, J. M. Genetic disorders in the growth hormone-insulin-like growth factor-I axis. Horm. Res. 2006, 66, 221-230.
91. Gicquel, C.; Le Bouc, Y. Hormonal regulation of fetal growth. Horm. Res. 2006, 65, 28-33.
92. Gallagher, E. J.; LeRoith, D. The proliferating role of insulin and insulin-like growth factors in cancer. Trends Endocrinol. Metab. 2010, 21, 610-618.
93. Freychet, P.; Roth, J.; Neville, D. M., Jr. Insulin receptors in the liver: Specific binding of [125I]insulin to the plasma membrane and its relation to insulin bioactivity. Proc. Natl. Acad. Sci. USA 1971, 68, 1833-1837.
94. Denley, A.; Wallace, J. C.; Cosgrove, L. J.; Forbes, B. E. The insulin receptor isoform exon 11-(IR-A) in cancer and other diseases: A review. Horm. Metab. Res. 2003, 35, 778-785.
95. Belfiore, A.; Frasca, F.; Pandini, G.; Sciacca, L.; Vigneri, R. Insulin receptor isoforms and insulin receptor/insulin-like growth factor receptor hybrids in physiology and disease. Endocr. Rev. 2009, 30, 586-623.
96. Frasca, F.; Pandini, G.; Scalia, P.; Sciacca, L.; Mineo, R.; Costantino, A.; Goldfine, I. D.; Belfiore, A.; Vigneri, R. Insulin receptor isoform A, a newly recognized, high-affinity insulin-like growth factor II receptor in fetal and cancer cells. Mol. Cell. Biol. 1999, 19, 3278-3288.
97. Denley, A.; Bonython, E. R.; Booker, G. W.; Cosgrove, L. J.; Forbes, B. E.; Ward, C. W.; Wallace, J. C. Structural determinants for high-affinity binding of insulin-like growth factor II to insulin receptor (IR)-A, the exon 11 minus isoform of the IR. Mol. Endocrinol. 2004, 18, 2502-2512.
98. Slaaby, R.; Schaffer, L.; Lautrup-Larsen, I.; Andersen, A. S.; Shaw, A. C.; Mathiasen, I. S.; Brandt, J. Hybrid receptors formed by insulin receptor (IR) and insulin-like growth factor I receptor (IGF-IR) have low insulin and high IGF-1 affinity irrespective of the IR splice variant. J. Biol. Chem. 2006, 281, 25869-25874.
99. Benyoucef, S.; Surinya, K. H.; Hadaschik, D.; Siddle, K. Characterization of insulin/IGF hybrid receptors: Contributions of the insulin receptor L2 and Fn1 domains and the alternatively spliced exon 11 sequence to ligand binding and receptor activation. Biochem. J. 2007, 403, 603-613.
100. De Meyts, P. Insulin and insulin-like growth factors: The paradox of signaling specificity. Growth Horm. IGF Res. 2002, 12, 81-83.
101. Dupont, J.; LeRoith, D. Insulin and insulin-like growth factor I receptors: Similarities and differences in signal transduction. Horm. Res. 2001, 55, 22-26.
102. Jui, H. Y.; Suzuki, Y.; Accili, D.; Taylor, S. I. Expression of a cDNA encoding the human insulin receptor-related receptor. J. Biol. Chem. 1994, 269, 22446-22452.
103. Zhang, B.; Roth, R. A. The insulin receptor-related receptor. Tissue expression, ligand binding specificity, and signaling capabilities. J. Biol. Chem. 1992, 267, 18320-18328.
104. Hirayama, I.; Tamemoto, H.; Yokota, H.; Kubo, S. K.; Wang, J.; Kuwano, H.; Nagamachi, Y.; Takeuchi, T.; Izumi, T. Insulin receptor-related receptor is expressed in pancreatic beta-cells and stimulates tyrosine phosphorylation of insulin receptor substrate-1 and-2. Diabetes 1999, 48, 1237-1244.
105. Mathi, S. K.; Chan, J.; Watt, V. M. Insulin receptor-related receptor messenger ribonucleic acid: Quantitative distribution and localization to subpopulations of epithelial cells in stomach and kidney. Endocrinology 1995, 136, 4125-4132.
106. Deyev, I. E.; Sohet, F.; Vassilenko, K. P.; Serova, O. V.; Popova, N. V.; Zozulya, S. A.; Burova, E. B.; Houillier, P.; Rzhevsky, D. I.; Berchatova, A. A.; et al. Insulin receptor-related receptor as an extracellular alkali sensor. Cell Metab. 2011, 13, 679-689.
107. Nef, S.; Verma-Kurvari, S.; Merenmies, J.; Vassalli, J. D.; Efstratiadis, A.; Accili, D.; Parada, L. F. Testis determination requires insulin receptor family function in mice. Nature 2003, 426, 291-295.
108. Adams, T. E.; Epa, V. C.; Garrett, T. P.; Ward, C. W. Structure and function of the type 1 insulin-like growth factor receptor. Cell. Mol. Life Sci. 2000, 57, 1050-1093.
109. Ward, C. W.; Garrett, T. P. Structural relationships between the insulin receptor and epidermal growth factor receptor families and other proteins. Curr. Opin. Drug Discov. Dev. 2004, 7, 630-638.
110. Hubbard, S. R. Juxtamembrane autoinhibition in receptor tyrosine kinases. Nat. Rev. Mol. Cell Biol. 2004, 5, 464-471.
111. Cheng, I.; Stram, D. O.; Penney, K. L.; Pike, M.; Le Marchand, L.; Kolonel, L. N.; Hirschhorn, J.; Altshuler, D.; Henderson, B. E.; Freedman, M. L. Common genetic variation in IGF1 and prostate cance risk in the multiethnic cohort. J. Natl. Cancer Inst. 2006, 98, 123-134.
112. Cohen, P. The twentieth centrury struggle to decipher insulin signaling. Nat. Rev. Mol. Cell Biol. 2006, 7, 867-873.
113. Taniguchi, C. M.; Emanuelli, B.; Kahn, C. R. Critical nodes in signaling pathways: Insights into insulin action. Nat. Rev. Mol. Cell Biol. 2006, 7, 85-96.
114. Zaid, H.; Antonescu, C. N.; Randhawa, V. K.; Klip, A. Insulin action on glucose transporters through molecular switches, tracks and tethers. Biochem. J. 2008, 413, 201-215.
115. Yarden, Y.; Schlessinger, J. Epidermal growth factor induces rapid, reversible aggregation of the purified epidermal growth factor receptor. Biochemistry 1987, 26, 1443-1451.
116. Boni-Schnetzler, M.; Pilch, P. F. Mechanism of epidermal growth factor receptor autophosphorylation and high-affinity binding. Proc. Natl. Acad. Sci. USA 1987, 84, 7832-7836.
117. Weiss, F. U.; Daub, H.; Ullrich, A. Novel mechanisms of RTK signal generation. Curr. Opin. Genet. Dev. 1997, 7, 80-86.
118. Canals, F. Signal transmission by epidermal growth factor receptor: Coincidence of activation and dimerization. Biochemistry 1992, 31, 4493-4501.
119. Cormack, B. P.; Valdivia, R. H.; Falkow, S. FACS-optimized mutants of the green fluorescent protein (GFP). Gene 1996, 173, 33-38.
120. Tsien, R. Y. The green fluorescent protein. Annu. Rev. Biochem. 1998, 67, 509-544.
121. Nagai, T.; Ibata, K.; Park, E. S.; Kubota, M.; Mikoshiba, K.; Miyawaki, A. A variant of yellow fluorescent protein with fast and efficient maturation for cell-biological applications. Nat. Biotechnol. 2002, 20, 87-90.
122. Knebel, A.; Rahmsdorf, H. J.; Ullrich, A.; Herrlich, P. Dephosphorylation of receptor tyrosine kinases as target of regulation by radiation, oxidants or alkylating agents. EMBO J. 1996, 15, 5314-5325.
123. Nagy, P.; Claus, J.; Jovin, T. M.; Arndt-Jovin, D. J. Distribution of resting and ligand-bound ErbB1 and ErbB2 receptor tyrosine kinases in living cells using number and brightness analysis. Proc. Natl. Acad. Sci. USA 2010, 107, 16524-16529.
124. Sawano, A.; Takayama, S.; Matsuda, M.; Miyawaki, A. Lateral propagation of EGF signaling after local stimulation is dependent on receptor density. Dev. Cell 2002, 3, 245-257.
125. Arevalo, J. C.; Conde, B.; Hempstead, B. L.; Chao, M. V.; Martin-Zanca, D.; Perez, P. TrkA immunoglobulin-like ligand binding domains inhibit spontaneous activation of the receptor. Mol. Cell. Biol. 2000, 20, 5908-5916.
126. Ohira, K.; Shimizu, K.; Hayashi, M. TrkB dimerization during development of the prefrontal cortex of the macaque. J. Neurosci. Res. 2001, 65, 463-469.
127. Mischel, P. S.; Umbach, J. A.; Eskandari, S.; Smith, S. G.; Gundersen, C. B.; Zampighi, G. A. Nerve growth factor signals via preexisting TrkA receptor oligomers. Biophys. J. 2002, 83, 968-976.
128. Vilar, M.; Charalampopoulos, I.; Kenchappa, R. S.; Simi, A.; Karaca, E.; Reversi, A.; Choi, S.; Bothwell, M.; Mingarro, I.; Friedman, W. J.; Schiavo, G.; Bastiaens, P. I.; Verveer, P. J.; Carter, B. D.; Ibanez, C. F. Activation of the p75 neurotrophin receptor through conformational rearrangement of disulphide-linked receptor dimers. Neuron 2009, 62, 72-83.
129. Marchetti, L.; Callegari, A.; Luin, S.; Signore, G.; Viegi, A.; Beltram, F.; Cattaneo, A. Ligand signature in the membrane dynamics of single TrkA receptor molecules. J. Cell Sci. 2013, 126, 4445-4456.
130. He, X. L.; Garcia, K. C. Structure of nerve growth factor complexed with the shared neurotrophin receptor p75. Science 2004, 304, 870-875.
131. Wehrman, T.; He, X.; Raab, B.; Dukipatti, A.; Blau, H.; Garcia, K. C. Structural and mechanistic insights into nerve growth factor interactions with the TrkA and p75 receptors. Neuron 2007, 53, 25-38.
132. Iacaruso, M. F.; Galli, S.; Marti, M.; Villalta, J. I.; Estrin, D. A.; Jares-Erijman, E. A.; Pietrasanta, L. I. Structural model for p75(NTR)-TrkA intracellular domain interaction: A combined FRET and bioinformatics study. J. Mol. Biol. 2011, 414, 681-698.
133. Matusica, D.; Skeldal, S.; Sykes, A. M.; Palstra, N.; Sharma, A.; Coulson, E. J. An intracellular domain fragment of the p75 neurotrophin receptor (p75(NTR) enhances tropomyosin receptor kinase A (TrkA) receptor function. J. Biol. Chem. 2013, 288, 11144-11154.
134. Massague, J.; Pilch, P. F.; Czech, M. P. Electrophoretic resolution of three major insulin receptor structures with unique subunit stoichiometries. Proc. Natl. Acad. Sci. USA 1980, 77, 7137-7141.
135. Ullrich, A.; Bell, J. R.; Chen, E. Y.; Herrera, R.; Petruzzelli, L. M.; Dull, T. J.; Gray, A.; Coussens, L.; Liao, Y. C.; Tsubokawa, M.; et al. Human insulin receptor and its relationship to the tyrosine kinase family of oncogenes. Nature 1985, 313, 756-761.
136. Ebina, Y.; Ellis, L.; Jarnagin, K.; Edery, M.; Graf, L.; Clauser, E.; Ou, J. H.; Masiarz, F.; Kan, Y. W.; Goldfine, I. D.; et al. The human insulin receptor cDNA: The structural basis for hormone-activated transmembrane signaling. Cell 1985, 40, 747-58.
137. Moxham, C. P.; Duronio, V.; Jacobs, S. Insulin-like growth factor I receptor beta-subunit heterogeneity. Evidence for hybrid tetramers composed of insulin-like growth factor I and insulin receptor heterodimers. J. Biol. Chem. 1989, 264, 13238-13244.
138. Soos, M. A.; Siddle, K. Immunological relationships between receptors for insulin and insulin-like growth factor I. Evidence for structural heterogeneity of insulin-like growth factor I receptors involving hybrids with insulin receptors. Biochem. J. 1989, 263, 553-563.
139. Federici, M.; Porzio, O.; Zucaro, L.; Giovannone, B.; Borboni, P.; Marini, M. A.; Lauro, D.; Sesti, G. Increased abundance of insulin/IGF-I hybrid receptors in adipose tissue from NIDDM patients. Mol. Cell Endocrinol. 1997, 135, 41-47.
140. Bailyes, E. M.; Nave, B. T.; Soos, M. A.; Orr, S. R.; Hayward, A. C.; Siddle, K. Insulin receptor/IGF-I receptor hybrids are widely distributed in mammalian tissues: Quantification of individual receptor species by selective immunoprecipitation and immunoblotting. Biochem. J. 1997, 327, 209-215.
141. Sandhu, M. S.; Dunger, D. B.; Giovannucci, E. L. Insulin, insulin-like growth factor-I (IGF-I), IGF binding proteins, their biologic interactions, and colorectal cancer. J. Natl. Cancer Inst. 2002, 94, 972-980.
142. Cho, H. S.; Leahy, D. J. Structure of the extracellular region of HER3 reveals an interdomain tether. Science 2002, 297, 1330-1333.
143. Ferguson, K. M.; Berger, M. B.; Mendrola, J. M.; Cho, H. S.; Leahy, D. J.; Lemmon, M. A. EGF activates its receptor by removing interactions that autoinhibit ectodomain dimerization. Moll. Cell 2003, 11, 507-517.
144. Bouyain, S.; Longo, P. A.; Li, S.; Ferguson, K. M.; Leahy, D. J. The extracellular region of ErbB4 adopts a tethered conformation in the absence of ligand. Proc. Natl. Acad. Sci. USA 2005, 102, 15024-15029.
145. Ferguson, K. M. Structure-based view of epidermal growth factor receptor regulation. Annu. Rev. Biophys. 2008, 37, 353-373.
146. Garrett, T. P.; McKern, N. M.; Lou, M.; Elleman, T. C.; Adams, T. E.; Lovrecz, G. O.; Zhu, H. J.; Walker, F.; Frenkel, M. J.; Hoyne, P. A.; et al. Crystal structure of a truncated epidermal growth factor receptor extracellular domain bound to transforming growth factor alpha. Cell 2002, 110, 763-773.
147. Ogiso, H.; Ishitani, R.; Nureki, O.; Fukai, S.; Yamanaka, M.; Kim, J. H.; Saito, K.; Sakamoto, A.; Inoue, M.; Shirouzu, M.; et al. Crystal structure of the complex of human epidermal growth factor and receptor extracellular domains. Cell 2002, 110, 775-787.
148. Berezov, A.; Chen, J.; Liu, Q.; Zhang, H. T.; Greene, M. I.; Murali, R. Disabling receptor ensembles with rationally designed interface peptidomimetics. J. Biol. Chem. 2002, 277, 28330-28339.
149. Walker, F.; Orchard, S. G.; Jorissen, R. N.; Hall, N. E.; Zhang, H. H.; Hoyne, P. A.; Adams, T. E.; Johns, T. G.; Ward, C.; Garrett, T. P.; et al. CR1/CR2 interactions modulate the functions of the cell surface epidermal growth factor receptor. J. Biol. Chem. 2004, 279, 22387-22398.
150. Cho, H. S.; Mason, K.; Ramyar, K. X.; Stanley, A. M.; Gabelli, S. B.; Denney, D. W., Jr.; Leahy, D. J. Structure of the extracellular region of HER2 alone and in complex with the Herceptin Fab. Nature 2003, 421, 756-760.
151. Garrett, T. P.; McKern, N. M.; Lou, M.; Elleman, T. C.; Adams, T. E.; Lovrecz, G. O.; Kofler, M.; Jorissen, R. N.; Nice, E. C.; Burgess, A. W.; et al. The crystal structure of a truncated ErbB2 ectodomain reveals an active conformation, poised to interact with other ErbB receptors. Mol. Cell 2003, 11, 495-505.
152. Jura, N.; Endres, N. F.; Engel, K.; Deindl, S.; Das, R.; Lamers, M. H.; Wemmer, D. E.; Zhang, X.; Kuriyan, J. Mechanism for activation of the EGF receptor catalytic domain by the juxtamembrane segment. Cell 2009, 137, 1293-1307.
153. Zhang, X.; Gureasko, J.; Shen, K.; Cole, P. A.; Kuriyan, J. An allosteric mechanism for activation of the kinase domain of epidermal growth factor receptor. Cell 2006, 125, 1137-1149.
154. Stamos, J.; Sliwkowski, M. X.; Eigenbrot, C. Structure of the epidermal growth factor receptor kinase domain alone and in complex with a 4-anilinoquinazoline inhibitor. J. Biol. Chem. 2002, 277, 46265-46272.
155. Huse, M.; Kuriyan, J. The conformational plasticity of protein kinases. Cell 2002, 109, 275-282.
156. Jeffrey, P. D.; Russo, A. A.; Polyak, K.; Gibbs, E.; Hurwitz, J.; Massague, J.; Pavletich, N. P. Mechanism of CDK activation revealed by the structure of a cyclinA-CDK2 complex. Nature 1995, 376, 313-320.
157. Red Brewer, M.; Choi, S. H.; Alvarado, D.; Moravcevic, K.; Pozzi, A.; Lemmon, M. A.; Carpenter, G. The juxtamembrane region of the EGF receptor functions as an activation domain. Mol. Cell 2009, 34, 641-651.
158. Jing, S.; Tapley, P.; Barbacid, M. Nerve growth factor mediates signal transduction through trk homodimer receptors. Neuron 1992, 9, 1067-1079.
159. Bothwell, M. A.; Shooter, E. M. Dissociation equilibrium constant of beta nerve growth factor. J. Biol. Chem. 1977, 252, 8532-8536.
160. McDonald, N. Q.; Lapatto, R.; Murray-Rust, J.; Gunning, J.; Wlodawer, A.; Blundell, T. L. New protein fold revealed by a 2. 3-Å resolution crystal structure of nerve growth factor. Nature 1991, 354, 411-414.
161. Radziejewski, C.; Robinson, R. C.; DiStefano, P. S.; Taylor, J. W. Dimeric structure and conformational stability of brain-derived neurotrophic factor and neurotrophin-3. Biochemistry 1992, 31, 4431-4436.
162. Ibanez, C. F.; Ilag, L. L.; Murray-Rust, J.; Persson, H. An extended surface of binding to Trk tyrosine kinase receptors in NGF and BDNF allows the engineering of a multifunctional pan-neurotrophin. EMBO J. 1993, 12, 2281-2293.
163. Artim, S. C.; Mendrola, J. M.; Lemmon, M. A. Assessing the range of kinase autoinhibition mechanisms in the insulin receptor family. Biochem. J. 2012, 448, 213-220.
164. Vilar, M.; Charalampopoulos, I.; Kenchappa, R. S.; Reversi, A.; Klos-Applequist, J. M.; Karaca, E.; Simi, A.; Spuch, C.; Choi, S.; Friedman, W. J.; et al. Ligand-independent signaling by disulfide-crosslinked dimers of the p75 neurotrophin receptor. J. Cell Sci. 2009, 122, 3351-3357.
165. Li, S.; Covino, N. D.; Stein, E. G.; Till, J. H.; Hubbard, S. R. Structural and biochemical evidence for an autoinhibitory role for tyrosine 984 in the juxtamembrane region of the insulin receptor. J. Biol. Chem. 2003, 278, 26007-26014.
166. Hubbard, S. R. The insulin receptor: Both a prototypical and atypical receptor tyrosine kinase. Cold Spring Harb. Perspect. Biol. 2013, 5, a008946.
167. Hubbard, S. R.; Wei, L.; Ellis, L.; Hendrickson, W. A. Crystal structure of the tyrosine kinase domain of the human insulin receptor. Nature 1994, 372, 746-754.
168. Munshi, S.; Kornienko, M.; Hall, D. L.; Reid, J. C.; Waxman, L.; Stirdivant, S. M.; Darke, P. L.; Kuo, L. C. Crystal structure of the Apo, unactivated insulin-like growth factor-1 receptor kinase. Implication for inhibitor specificity. J. Biol. Chem. 2002, 277, 38797-38802.
169. Menting, J. G.; Whittaker, J.; Margetts, M. B.; Whittaker, L. J.; Kong, G. K.; Smith, B. J.; Watson, C. J.; Zakova, L.; Kletvikova, E.; Jiracek, J.; et al. How insulin engages its primary binding site on the insulin receptor. Nature 2013, 493, 241-245.
170. Schlessinger, J. Allosteric regulation of the epidermal growth factor receptor kinase. J. Cell Biol. 1986, 103, 2067-2072.
171. Macdonald, J. L.; Pike, L. J. Heterogeneity in EGF-binding affinities arises from negative cooperativity in an aggregating system. Proc. Natl. Acad. Sci. USA 2008, 105, 112-117.
172. Macdonald-Obermann, J. L.; Pike, L. J. The intracellular juxtamembrane domain of the epidermal growth factor (EGF) receptor is responsible for the allosteric regulation of EGF binding. J. Biol. Chem. 2009, 284, 13570-13576.
173. De Meyts, P.; Roth, J.; Neville, D. M., Jr.; Gavin, J. R., III; Lesniak, M. A. Insulin interactions with its receptors: Experimental evidence for negative cooperativity. Biochem. Biophys. Res. Commun. 1973, 55, 154-161.
174. Shoyab, M.; De Larco, J. E.; Todaro, G. J. Biologically active phorbol esters specifically alter affinity of epidermal growth factor membrane receptors. Nature 1979, 279, 387-391.
175. Magun, B. E.; Matrisian, L. M.; Bowden, G. T. Epidermal growth factor. Ability of tumor promoter to alter its degradation, receptor affinity and receptor number. J. Biol. Chem. 1980, 255, 6373-6381.
176. King, A. C.; Cuatrecasas, P. Resolution of high and low affinity epidermal growth factor receptors. Inhibition of high affinity component by low temperature, cycloheximide, and phorbol esters. J. Biol. Chem. 1982, 257, 3053-3060.
177. Kawamoto, T.; Sato, J. D.; Le, A.; Polikoff, J.; Sato, G. H.; Mendelsohn, J. Growth stimulation of A431 cells by epidermal growth factor: Identification of high-affinity receptors for epidermal growth factor by an anti-receptor monoclonal antibody. Proc. Natl. Acad. Sci. USA 1983, 80, 1337-1341.
178. Defize, L. H.; Boonstra, J.; Meisenhelder, J.; Kruijer, W.; Tertoolen, L. G.; Tilly, B. C.; Hunter, T.; van Bergen en Henegouwen, P. M.; Moolenaar, W. H.; de Laat, S. W. Signal transduction by epidermal growth factor occurs through the subclass of high affinity receptors. J. Cell Biol. 1989, 109, 2495-2507.
179. Bellot, F.; Moolenaar, W.; Kris, R.; Mirakhur, B.; Verlaan, I.; Ullrich, A.; Schlessinger, J.; Felder, S. High-affinity epidermal growth factor binding is specifically reduced by a monoclonal antibody, and appears necessary for early responses. J. Cell Biol. 1990, 110, 491-502.
180. Hunter, T.; Ling, N.; Cooper, J. A. Protein kinase C phosphorylation of the EGF receptor at a threonine residue close to the cytoplasmic face of the plasma membrane. Nature 1984, 311, 480-483.
181. Özcan, F.; Klein, P.; Lemmon, M. A.; Lax, I.; Schlessinger, J. On the nature of low-and high-affinity EGF receptors on living cells. Proc. Natl. Acad. Sci. USA 2006, 103, 5735-5740.
182. Livneh, E.; Prywes, R.; Kashles, O.; Reiss, N.; Sasson, I.; Mory, Y.; Ullrich, A.; Schlessinger, J. Reconstitution of human epidermal growth factor receptors and its deletion mutants in cultured hamster cells. J. Biol. Chem. 1986, 261, 12490-12497.
183. Wofsy, C.; Goldstein, B.; Lund, K.; Wiley, H. S. Implications of epidermal growth factor (EGF) induced egf receptor aggregation. Biophys. J. 1992, 63, 98-110.
184. Lemmon, M. A.; Bu, Z.; Ladbury, J. E.; Zhou, M.; Pinchasi, D.; Lax, I.; Engelman, D. M.; Schlessinger, J. Two EGF molecules contribute additively to stabilization of the EGFR dimer. EMBO J. 1997, 16, 281-294.
185. Klein, P.; Mattoon, D.; Lemmon, M. A.; Schlessinger, J. A structure-based model for ligand binding and dimerization of EGF receptors. Proc. Natl. Acad. Sci. USA 2004, 101, 929-934.
186. Holbrook, M. R.; Slakey, L. L.; Gross, D. J. Thermodynamic mixing of molecular states of the epidermal growth factor receptor modulates macroscopic ligand binding affinity. Biochem. J. 2000, 352, 99-108.
187. Mayawala, K.; Vlachos, D. G.; Edwards, J. S. Heterogeneities in EGF receptor density at the cell surface can lead to concave up scatchard plot of EGF binding. FEBS Lett. 2005, 579, 3043-3047.
188. Alvarado, D.; Klein, D. E.; Lemmon, M. A. Structural basis for negative cooperativity in growth factor binding to an EGF receptor. Cell 2010, 142, 568-579.
189. Liu, P.; Cleveland, T. E., 4th; Bouyain, S.; Byrne, P. O.; Longo, P. A.; Leahy, D. J. A single ligand is sufficient to activate EGFR dimers. Proc. Natl. Acad. Sci. USA 2012, 109, 10861-10866.
190. Sako, Y.; Minoghchi, S.; Yanagida, T. Single-molecule imaging of EGFR signalling on the surface of living cells. Nat. Cell Biol. 2000, 2, 168-172.
191. Lu, C.; Mi, L. Z.; Schurpf, T.; Walz, T.; Springer, T. A. Mechanisms for kinase-mediated dimerization of the epidermal growth factor receptor. J. Biol. Chem. 2012, 287, 38244-38253.
192. Adak, S.; DeAndrade, D.; Pike, L. J. The tethering arm of the EGF receptor is required for negative cooperativity and signal transduction. J. Biol. Chem. 2011, 286, 1545-1555.
193. Adak, S.; Yang, K. S.; Macdonald-Obermann, J.; Pike, L. J. The membrane-proximal intracellular domain of the epidermal growth factor receptor underlies negative cooperativity in ligand binding. J. Biol. Chem. 2011, 286, 45146-45155.
194. Downward, J.; Waterfield, M. D.; Parker, P. J. Autophosphorylation and protein kinase C phosphorylation of the epidermal growth factor receptor. Effect on tyrosine kinase activity and ligand binding affinity. J. Biol. Chem. 1985, 260, 14538-14546.
195. Mahadeo, D.; Kaplan, L.; Chao, M. V.; Hempstead, B. L. High affinity nerve growth factor binding displays a faster rate of association than p140trk binding. Implications for multi-subunit polypeptide receptors. J. Biol. Chem. 1994, 269, 6884-6891.
196. Bothwell, M. Keeping track of neurotrophin receptors. Cell 1991, 65, 915-918.
197. Chao, M. V. Neurotrophin receptors: A window into neuronal differentiation. Neuron 1992, 9, 583-593.
198. Vesa, J.; Kruttgen, A.; Shooter, E. M. p75 reduces TrkB tyrosine autophosphorylation in response to brain-derived neurotrophic factor and neurotrophin 4/5. J. Biol. Chem. 2000, 275, 24414-24420.
199. Barker, P. A. High affinity not in the vicinity? Neuron 2007, 53, 1-4.
200. Esposito, D.; Patel, P.; Stephens, R. M.; Perez, P.; Chao, M. V.; Kaplan, D. R.; Hempstead, B. L. The cytoplasmic and transmembrane domains of the p75 and Trk A receptors regulate high affinity binding to nerve growth factor. J. Biol. Chem. 2001, 276, 32687-32695.
201. Frattali, A. L.; Treadway, J. L.; Pessin, J. E. Transmembrane signaling by the human insulin receptor kinase. Relationship between intramolecular beta subunit trans-and cis-autophosphorylation and substrate kinase activation. J. Biol. Chem. 1992, 267, 19521-19528.
202. De Meyts, P.; Whittaker, J. Structural biology of insulin and IGF1 receptors: Implication for drug design. Nat. Rev. Drug Discov. 2002, 1, 769-783.
203. De Meyts, P. The structural basis of insulin and insulin-like growth factor-I receptor binding and negative co-operativity, and its relevance to mitogenic versus metabolic signaling. Diabetologia 1994, 37, S135-S148.
204. De Meyts, P. The insulin receptor: A prototype for dimeric, allosteric membrane receptors? Trends Biochem. Sci. 2008, 33, 376-384.
205. Kiselyov, V. V.; Versteyhe, S.; Gauguin, L.; De Meyts, P. Harmonic oscillator model of the insulin and IGF1 receptors' allosteric binding and activation. Mol. Syst. Biol. 2009, 5, 243.
206. Knudsen, L.; De Meyts, P.; Kiselyov, V. V. Insight into the molecular basis for the kinetic differences between the two insulin receptor isoforms. Biochem. J. 2011, 440, 397-403.
207. Boni-Schnetzler, M.; Scott, W.; Waugh, S. M.; DiBella, E.; Pilch, P. F. The insulin receptor. Structural basis for high affinity ligand binding. J. Biol. Chem. 1987, 262, 8395-401.
208. Sweet, L. J.; Morrison, B. D.; Pessin, J. E. Isolation of functional alpha beta heterodimers from the purified human placental alpha 2 beta 2 heterotetrameric insulin receptor complex. A structural basis for insulin binding. J. Biol. Chem. 1987, 262, 6939-6942.
209. Pang, D. T.; Shafer, J. A. Stoichiometry for the binding of insulin to insulin receptors in adipocyte membranes. J. Biol. Chem. 1983, 258, 2514-2518.
210. Pang, D. T.; Shafer, J. A. Evidence that insulin receptor from human placenta has a high affinity for only one molecule of insulin. J. Biol. Chem. 1984, 259, 8589-8596.
211. Hoyne, P. A.; Elleman, T. C.; Adams, T. E.; Richards, K. M.; Ward, C. W. Properties of an insulin receptor with an IGF-1 receptor loop exchange in the cysteine-rich region. FEBS Lett. 2000, 469, 57-60.
212. Marsh, J. W.; Westley, J.; Steiner, D. F. Insulin-receptor interactions. Presence of a positive cooperative effect. J. Biol. Chem. 1984, 259, 6641-6649.
213. Riedel, H.; Dull, T. J.; Schlessinger, J.; Ullrich, A. A chimaeric receptor allows insulin to stimulate tyrosine kinase activity of epidermal growth factor receptor. Nature 1986, 324, 68-70.